Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulatory Harmonization Takes Center Stage At IFPMA Asia Event

This article was originally published in PharmAsia News

Executive Summary

KUALA LUMPUR, Malaysia - Industry and regulators in Asia are mapping out strategies for regulatory harmonization, mostly borrowed from the U.S. and European Union experiences, in an effort to help the rapidly growing Asian pharmaceutical markets
Advertisement

Related Content

Would New Drug Launches Speed Up With A Pan-Asia Regulatory Framework? - Biopharma Asia Conference
Would New Drug Launches Speed Up With A Pan-Asia Regulatory Framework? - Biopharma Asia Conference
Forget China And India, Clinical Trial Opportunities In Malaysia and South Korea
Forget China And India, Clinical Trial Opportunities In Malaysia and South Korea
Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi In Hot Pursuit Of Sources Of Innovation in Asia: An Interview with PharmAsia News
Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi In Hot Pursuit Of Sources Of Innovation in Asia: An Interview with PharmAsia News
East Asian Regulators Collaborate To Reduce Drug Lags (Part 1 of 2)
East Asian Regulators Collaborate To Reduce Drug Lags (Part 1 of 2)
GMP Inspection Results Can No Longer Stay Within Borders, Says U.S. FDA
Global Drug Regulators And Manufacturers Grapple With How To Ensure Global Quality Standards (Part 1 Of 2)
Advertisement
UsernamePublicRestriction

Register

SC067902

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel